← Back to headlines
CytomX outlines registrational trial plans for Varseta-M in third-line colorectal cancer with initial study start in 2027
16 Mar, 16:05 — 16 Mar, 16:05
Sources
Showing 1 of 1 sources
Related Stories
Health workers’ group rejects compressed workweek, seeks pay hike
just now
MMDA gives field personnel 30-minute breaks to prevent heat illness
just now
Nigeria losing health workers to “japa” crisis, minister tells global summit
just now
These four healthy drinks help with weight loss better than plain water
17m ago